# Treatment of Chronic Hepatitis C Infection by Ledipasvir/Sofosbuvir in Naïve Children

> **NCT05091008** · PHASE2 · COMPLETED · sponsor: **Mansoura University Children Hospital** · enrollment: 50 (actual)

## Conditions studied

- Hepatitis C, Chronic

## Interventions

- **DRUG:** Ledipasvir-Sofosbuvir 90 Mg-400 Mg Oral Tablet

## Key facts

- **NCT ID:** NCT05091008
- **Lead sponsor:** Mansoura University Children Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-01
- **Primary completion:** 2019-08-30
- **Final completion:** 2020-03-10
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2021-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05091008

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05091008, "Treatment of Chronic Hepatitis C Infection by Ledipasvir/Sofosbuvir in Naïve Children". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05091008. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*